N. Vardakis

525 total citations
35 papers, 436 citations indexed

About

N. Vardakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, N. Vardakis has authored 35 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in N. Vardakis's work include Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). N. Vardakis is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). N. Vardakis collaborates with scholars based in Greece, United States and Cyprus. N. Vardakis's co-authors include Kostas Kalbakis, John Souglakos, S. Kakolyris, D. Mavroudis, Sofia Agelaki, Dora Hatzidaki, Vassilis Georgoulias, Maria Perraki, Stella Apostolaki and C. Kourousis and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

N. Vardakis

33 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Vardakis Greece	11	348	201	113	68	64	35	436
Audrey Hennequin France	11	410 1.2×	154 0.8×	81 0.7×	106 1.6×	102 1.6×	34	561
Giulia Grizzi Italy	12	262 0.8×	185 0.9×	70 0.6×	82 1.2×	41 0.6×	24	370
Virginia Palomar Coloma France	4	421 1.2×	190 0.9×	48 0.4×	42 0.6×	65 1.0×	5	481
Guoqiang Wang China	9	455 1.3×	227 1.1×	88 0.8×	89 1.3×	62 1.0×	24	561
Darren M. Kocs United States	9	219 0.6×	137 0.7×	57 0.5×	145 2.1×	109 1.7×	16	402
F. Daniel United Kingdom	8	232 0.7×	174 0.9×	93 0.8×	71 1.0×	144 2.3×	13	374
Keita Uchino Japan	12	215 0.6×	151 0.8×	39 0.3×	86 1.3×	59 0.9×	40	357
Nishi Kothari United States	12	238 0.7×	155 0.8×	74 0.7×	93 1.4×	70 1.1×	29	372
R. Houston Thompson United Kingdom	2	520 1.5×	207 1.0×	71 0.6×	92 1.4×	62 1.0×	4	637

Countries citing papers authored by N. Vardakis

Since Specialization

Citations

This map shows the geographic impact of N. Vardakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vardakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vardakis more than expected).

Fields of papers citing papers by N. Vardakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vardakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vardakis. The network helps show where N. Vardakis may publish in the future.

Co-authorship network of co-authors of N. Vardakis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Vardakis. A scholar is included among the top collaborators of N. Vardakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vardakis. N. Vardakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Syrios, John, Charalambos Kouroussis, Αthanasios Kotsakis, et al.. (2019). Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study. PubMed. 71(3). 182–190. 2 indexed citations

Messaritakis, Ippokratis, Maria Sfakianaki, Chara Papadaki, et al.. (2018). Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 82(5). 767–775. 18 indexed citations

Economopoulou, Panagiota, Leonidas Chelis, Aris Polyzos, et al.. (2016). Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG). Clinical & Translational Oncology. 19(3). 317–325. 7 indexed citations

Kentepozidis, Nikolaos, Ioannis Boukovinas, A. Kalykaki, et al.. (2014). Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 75(1). 153–160. 7 indexed citations

Xenidis, N., Maria Perraki, Stella Apostolaki, et al.. (2013). Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer. British Journal of Cancer. 108(3). 549–556. 25 indexed citations

Karachaliou, Niki, Ch. Kouroussis, Pavlos Papakotoulas, et al.. (2012). A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 69(5). 1345–1352. 2 indexed citations

Mountzios, Giannis, Christos Emmanouilidis, N. Vardakis, et al.. (2012). Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group. Lung Cancer. 77(1). 146–150. 33 indexed citations

Pallis, Athanasios, Athanasios Karampeazis, L. Vamvakas, et al.. (2011). Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group. Annals of Oncology. 22(11). 2448–2455. 12 indexed citations

Boukovinas, Ioannis, Nikolaos Androulakis, Nikolaos Kentepozidis, et al.. (2011). Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Cancer Chemotherapy and Pharmacology. 69(2). 351–356. 4 indexed citations

10.

Karampeazis, Athanasios, Lambros Vamvakas, Athina Agelidou, et al.. (2011). Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study. Clinical Lung Cancer. 12(3). 155–160. 17 indexed citations

11.

Pallis, Athanasios, Kostas Syrigos, Αthanasios Kotsakis, et al.. (2011). Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non–Small-Cell Lung Cancer Pretreated With Non–Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study. Clinical Lung Cancer. 12(2). 100–105. 6 indexed citations

12.

Pallis, Athanasios, Alexandra Voutsina, Nikolaos Kentepozidis, et al.. (2011). A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 13(2). 129–135. 8 indexed citations

13.

Vardakis, N., Ippokratis Messaritakis, Chara Papadaki, et al.. (2010). Prognostic Significance of the Detection of Peripheral Blood CEACAM5mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer. Clinical Cancer Research. 17(1). 165–173. 22 indexed citations

14.

Gioulbasanis, Ioannis, Zoe Giannousi, Emmanouil Saloustros, et al.. (2008). Prognostic value of Mini Nutritional Assessment (MNA) score in elderly lung-cancer patients. Critical Reviews in Oncology/Hematology. 68. S47–S47. 1 indexed citations

15.

Kalykaki, A., L. Vamvakas, Sofia Agelaki, et al.. (2006). A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors. Oncology. 71(3-4). 197–203. 7 indexed citations

16.

Xenidis, Nikolaos, Ioannis G. Vlachonikolis, D. Mavroudis, et al.. (2003). Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Annals of Oncology. 14(6). 849–855. 88 indexed citations

17.

Kouroussis, Ch., John Souglakos, Stylianos Kakolyris, et al.. (2001). Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study. Oncology. 61(1). 36–41. 16 indexed citations

18.

Kakolyris, S., John Souglakos, Ch. Kouroussis, et al.. (2001). A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer. Oncology. 60(3). 207–213. 5 indexed citations

19.

Mavroudis, Dimitriοs, C. Kourousis, N. Androulakis, et al.. (2000). Frontline Treatment of Advanced Gastric Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor (G-CSF). American Journal of Clinical Oncology. 23(4). 341–344. 82 indexed citations

20.

Kakolyris, S., Ch. Kouroussis, Kostas Kalbakis, et al.. (2000). Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin. Annals of Oncology. 11(6). 757–760. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact